TNXA and congenital adrenal hyperplasia: In either case, our results suggested that the real-gene-like variants throughout pseudogenes CYP21A1P and TNXA, as well as their underestimated allele frequency, should be considered as another obstacle to overcome in addition to the commonly accepted pseudogene homologue and copy number variations in terms of designing a comprehensive CAH test platform based on NGS methodologies.